ARTICLE | Distillery Therapeutics
Infectious disease
March 14, 2017 4:12 PM UTC
Mouse studies suggest inhibiting CD126 could help treat CMV. In a mouse model of CMV, a mAb against mouse CD126 decreased weight loss and viral load in the spleen compared with control IgG. Next steps...
BCIQ Company Profiles
BCIQ Target Profiles